The new drug, Kisunla, has the potential to be a blockbuster for the company and generate billions in revenue. But despite ...
Alzheimer’s patients can temporarily lessen their symptoms with a recent FDA-approved drug that removes amyloid, or protein, ...
It's not a cure-- but it is a step in the right direction.This month-- a new medication for alzheimer's, called 'kinsul'a, ...
The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by ...
The U.S. Food and Drug Administration on Tuesday approved another drug that slows cognitive and functional decline in people ...
Learn about the benefits of Kisunla, the newly approved Alzheimer's drug that can modestly slow disease progression in the ...
U.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing a new option for patients ...
For Dr. Jeffrey Cummings, a brain health researcher and professor at UNLV, this is an exciting time in the fight against ...
The FDA approved Kisunla, known chemically as donanemab ... aren’t yet setup to prescribe the new plaque-targeting Alzheimer's drugs. First, doctors need to confirm that patients with dementia ...
The U.S. Food and Drug Administration on Tuesday approved Eli Lilly's treatment for early Alzheimer's, making it the second ...